A human hepatocyte-bearing mouse: An animal model to predict drug metabolism and effectiveness in humans

PPAR Research

Volumn , Issue , 2009, Pages

  Yoshizato, Katsutoshi ^a,b   Tateno, Chise ^a  

^a PhoenixBio USA Corporation   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; CEFMETAZOLE; CYTOCHROME P450 ISOENZYME; FIBRIC ACID DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ARTICLE; CELL POPULATION; CHIMERA; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG TRANSPORT; EXPERIMENTAL MODEL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER CELL; NONHUMAN; SIGNAL TRANSDUCTION; VIRUS INFECTIVITY; XENOGRAFT;

EID: 72449189142     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2009/476217     Document Type: Article

References (76)

1. Yoshizato K., Tateno C., Utoh R., A human hepatocytes-bearing mouse: a novel animal model to study the mechanism of liver size control in mammals International Journal of Design Nature 2009 4 2 1 20
2. Nakatani K., Okuyama H., Shimahara Y., Cytoglobin/STAP, its unique localization in splanchnic fibroblast-like cells and function in organ fibrogenesis Laboratory Investigation 2004 84 1 91 101
3. Lemaigre F., Zaret K. S., Liver development update: new embryo models, cell lineage control, and morphogenesis Current Opinion in Genetics Development 2004 14 5 582 590
4. Michalopoulos G. K., Liver regeneration Journal of Cellular Physiology 2007 213 2 286 300
5. Rhim J. A., Sandgren E. P., Palmiter R. D., Brinster R. L., Complete reconstitution of mouse liver with xenogeneic hepatocytes Proceedings of the National Academy of Sciences of the United States of America 1995 92 11 4942 4946
6. Dandri M., Burda M. R., Trk E., Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus Hepatology 2001 33 4 981 988 (Pubitemid 32246649)
7. Mercer D. F., Schiller D. E., Elliott J. F., Hepatitis C virus replication in mice with chimeric human livers Nature Medicine 2001 7 8 927 933
8. Tateno C., Yoshizane Y., Saito N., Near completely humanized liver in mice shows human-type metabolic responses to drugs American Journal of Pathology 2004 165 3 901 912
9. Meuleman P., Libbrecht L., De Vos R., Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera Hepatology 2005 41 4 847 856
10. Kneteman N. M., Mercer D. F., Mice with chimeric human livers: who says supermodels have to be tall? Hepatology 2005 41 4 703 706
11. Nishimura M., Yokoi T., Tateno C., Induction of human CYP1A2 and CYP3A4 in primary culture of hepatocytes from chimeric mice with humanized liver Drug Metabolism and Pharmacokinetics 2005 20 2 121 126
12. Heckel J. L., Sandgren E. P., Degen J. L., Palmiter R. D., Brinster R. L., Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator Cell 1990 62 3 447 456
13. Sandgren E. P., Palmiter R. D., Heckel J. L., Daughterly C. C., Brinster R. L., Degen J. L., Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene Cell 1991 66 2 245 256
14. Rhim J. A., Sandgren E. P., Degen J. L., Palmiter R. D., Brinster R. L., Replacement of diseased mouse liver by hepatic cell transplantation Science 1994 263 5150 1149 1152
15. Kawada N., Kristensen D. B., Asahina K., Characterization of a stellate cell activation-associated protein (STAP) with peroxidase activity found in rat hepatic stellate cells The Journal of Biological Chemistry 2001 276 27 25318 25323
16. Nishimura M., Yoshitsugu H., Yokoi T., Evaluation of mRNA expression of human drug-metabolizing enzymes and transporters in chimeric mouse with humanized liver Xenobiotica 2005 35 9 877 890
17. Gonzalez F. J., Yu A.-M., Cytochrome P450 and xenobiotic receptor humanized mice Annual Review of Pharmacology and Toxicology 2006 46 41 64
18. Hewitt N. J., Lecluyse E. L., Ferguson S. S., Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations Xenobiotica 2007 37 10-11 1196 1224
19. Graham M. J., Lake B. G., Induction of drug metabolism: species differences and toxicological relevance Toxicology 2008 254 3 184 191
20. Bogaards J. J. P., Bertrand M., Jackson P., Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man Xenobiotica 2000 30 12 1131 1152
21. Caldwell J., The current status of attempts to predict species differences in drug metabolism Drug Metabolism Reviews 1981 12 2 221 237
22. Zanger U. M., Raimundo S., Eichelbaum M., Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry Naunyn-Schmiedebergs Archives of Pharmacology 2004 369 1 23 37
23. Yu A.-M., Idle J. R., Gonzalez F. J., Polymorphic cytochrome P450, 2D6: humanized mouse model and endogenous substrates Drug Metabolism Reviews 2004 36 2 243 277
24. Masubuchi Y., Iwasa T., Hosokawa S., Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes Journal of Pharmacology and Experimental Therapeutics 1997 282 3 1435 1441
25. Katoh M., Sawada T., Soeno Y., In vivo drug metabolism model for human cytochrome P450 enzyme using chimeric mice with humanized liver Journal of Pharmaceutical Sciences 2007 96 2 428 437
26. Bowen W. P., Carey J. E., Miah A., Measurement of cytochrome P450 gene induction in human hepatocytes, using quantitative real-time reverse transcriptase-polymerase chain reaction Drug Metabolism and Disposition 2000 28 7 781 788
27. Katoh M., Matsui T., Nakajima M., In vivo induction of human cytochrome P450 enzymes expressed in chimeric mice with humanized liver Drug Metabolism and Disposition 2005 33 6 754 763 (Pubitemid 40686628)
28. Toriyabe T., Nagata K., Takada T., Unveiling a new essential cis element for the transactivation of the CYP3A4 gene by xenobiotics Molecular Pharmacology 2009 75 3 677 684
29. Jones S. A., Moore L. B., Shenk J. L., The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution Molecular Endocrinology 2000 14 1 27 39
30. Cho I. J., Kim S. G., Oltipraz inhibits 3-methylcholanthrene induction of CYP1A1 by CCAAT/enhancer-binding protein activation The Journal of Biological Chemistry 2003 278 45 44103 44112
31. Bjornsson T. D., Callaghan J. T., Einolf H. J., The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective Drug Metabolism and Disposition 2003 31 7 815 832
32. Katoh M., Matsui T., Okumura H., Expression of human phase II enzymes in chimeric mice with humanized liver Drug Metabolism and Disposition 2005 33 9 1333 1340
33. Xie W., Yeuh M.-F., Radominska-Pandya A., Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 4150 4155
34. Kodama S., Koike C., Negishi M., Yamamoto Y., Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes Molecular and Cellular Biology 2004 24 18 7931 7940
35. Zhang J., Huang W., Chua S. S., Wei P., Moore D. D., Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR Science 2002 298 5592 422 424
36. Okumura H., Katoh M., Sawada T., Humanization of excretory pathway in chimeric mice with humanized liver Toxicological Sciences 2007 97 2 533 538 (Pubitemid 47073867)
37. Ko H., Novak E., Peters G. R., Pharmacokinetics of single-dose cefmetazole following intramuscular administration of cefmetazole sodium to healthy male volunteers Antimicrobial Agents and Chemotherapy 1989 33 4 508 512
38. Murakawa T., Sakamoto H., Fukada S., Pharmacokinetics of ceftizoxime in animals after parenteral dosing Antimicrobial Agents and Chemotherapy 1980 17 2 157 164 (Pubitemid 10128995)
39. Shoda J., Okada K., Inada Y., Bezafibrate induces multidrug-resistance P-glycoprotein 3 expression in cultured human hepatocytes and humanized livers of chimeric mice Hepatology Research 2007 37 7 548 556
40. Sarbah S. A., Younossi Z. M., Hepatitis C: an update on the silent epidemic Journal of Clinical Gastroenterology 2000 30 2 125 143
41. Meuleman P., Leroux-Roels G., The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV Antiviral Research 2008 80 3 231 238
42. Tsuge M., Hiraga N., Takaishi H., Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus Hepatology 2005 42 5 1046 1054
43. Nuclear Receptors Nomenclature Committee, A unified nomenclature system for the nuclear receptor superfamily Cell 1999 97 2 161 163
44. Yu S., Reddy J. K., Transcription coactivators for peroxisome proliferator-activated receptors Biochimica et Biophysica Acta 2007 1771 8 936 951
45. Michalik L., Auwerx J., Berger J. P., International union of pharmacology. LXI. Peroxisome proliferator-activated receptors Pharmacological Reviews 2006 58 4 726 741
46. Lock E. A., Mitchell A. M., Elcombe C. R., Biochemical mechanisms of induction of hepatic peroxisome proliferation Annual Review of Pharmacology and Toxicology 1989 29 145 163
47. Nemali M. R., Reddy M. K., Usuda N., Differential induction and regulation of peroxisomal enzyme: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens Toxicology and Applied Pharmacology 1989 97 1 72 87
48. Reddy J. K., Rao M. S., Peroxisome proliterators and cancer: mechanisms and implications Trends in Pharmacological Sciences 1986 7 438 443
49. Lalwani N. D., Fahl W. E., Reddy J. K., Detection of a nafenopin binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds Biochemical and Biophysical Research Communications 1983 116 2 388 393
50. Goldfischer S., Reddy J. K., Peroxisomes (microbodies) in cell pathology International Review of Experimental Pathology 1984 26 45 84
51. Issemann I., Green S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 1990 347 6294 645 650
52. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W., Control of the peroxisomal -oxidation pathway by a novel family of nuclear hormone receptors Cell 1992 68 5 879 887
53. Tachibana K., Yamasaki D., Ishimoto K., Doi T., The role of PPARs in cancer PPAR Research 2008 2008 15
54. Morimura K., Cheung C., Ward J. M., Reddy J. K., Gonzalez F. J., Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor to Wy-14,643-induced liver tumorigenesis Carcinogenesis 2006 27 5 1074 1080
55. Bentley P., Calder I., Elcombe C., Grasso P., Stringer D., Wiegand H.-J., Hepatic peroxisome proliferation in rodents and its significance for humans Food and Chemical Toxicology 1993 31 11 857 907
56. Holden P. R., Tugwood J. D., Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences Journal of Molecular Endocrinology 1999 22 1 1 8
57. Palmer C. N. A., Hsu M.-H., Griffin K. J., Raucy J. L., Johnson E. F., Peroxisome proliferator activated receptor- expression in human liver Molecular Pharmacology 1998 53 1 14 22
58. Tugwood J. D., Issemann I., Anderson R. G., Bundell K. R., McPheat W. L., Green S., The mouse peroxisome proliferator activated receptor recognizes a response element in the 5 ′ flanking sequence of the rat acyl CoA oxidase gene The EMBO Journal 1992 11 2 433 439
59. Zhang B., Marcus S. L., Saijadi F. G., Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase Proceedings of the National Academy of Sciences of the United States of America 1992 89 16 7541 7545
60. Bardot O., Aldridge T. C., Latruffe N., Green S., PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene Biochemical and Biophysical Research Communications 1993 192 1 37 45
61. Aldridge T. C., Tugwood J. D., Green S., Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription Biochemical Journal 1995 306, part 2 473 479
62. Schoonjans K., Peinado-Onsurbe J., Lefebvre A.-M., PPAR and PPAR activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene The EMBO Journal 1996 15 19 5336 5348
63. Peters J. M., Hennuyer N., Staels B., Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor -deficient mice The Journal of Biological Chemistry 1997 272 43 27307 27312
64. Cheung C., Akiyama T. E., Ward J. M., Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor Cancer Research 2004 64 11 3849 3854
65. Lee S. S., Pineau T., Drago J., Targeted disruption of the isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Molecular and Cellular Biology 1995 15 6 3012 3022
66. Lee C.-H., Olson P., Evans R. M., Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors Endocrinology 2003 144 6 2201 2207
67. Smit J. J. M., Schinkel A. H., Oude Elferink R. P. J., Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease Cell 1993 75 3 451 462
68. Smith A. J., de Vree J. M. L., Ottenhoff R., Oude Elferink R. P. J., Schinkel A. H., Borst P., Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-) mice Hepatology 1998 28 2 530 536
69. Rosmorduc O., Hermelin B., Boelle P.-Y., Parc R., Taboury J., Poupon R., ABCB4 gene mutation-associated cholelithiasis in adults Gastroenterology 2003 125 2 452 459
70. Kok T., Bloks V. W., Wolters H., Peroxisome proliferator-activated receptor (PPAR )-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice Biochemical Journal 2003 369, part 3 539 547
71. Chianale J., Vollrath V., Wielandt A. M., Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse Biochemical Journal 1996 314, part 3 781 786
72. Kurihara T., Niimi A., Maeda A., Shigemoto M., Yamashita K., Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid American Journal of Gastroenterology 2000 95 10 2990 2992
73. Krey G., Braissant O., LHorset F., Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay Molecular Endocrinology 1997 11 6 779 791
74. Inoue I., Itoh F., Aoyagi S., Fibrate and statin synergistically increase the transcriptional activities of PPAR /RXR and decrease the transactivation of NF B Biochemical and Biophysical Research Communications 2002 290 1 131 139
75. Shoda J., Inada Y., Tsuji A., Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPAR -mediated redistribution of ABCB4 Journal of Lipid Research 2004 45 10 1813 1825
76. Masumoto N., Tateno C., Tachibana A., GH enhances proliferation of human hepatocytes grafted into immunodeficient mice with damaged liver Journal of Endocrinology 2007 194 3 529 537